Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / CUE - Cue Biopharma: Too Long To Arrive At Topline Trial Data

CUE - Cue Biopharma: Too Long To Arrive At Topline Trial Data

Cue Biopharma Inc.
  • CUE has been in the market since 2014, and they still haven't completed a phase 1 trial.
  • They plan to announce topline phase 1 data in July.
  • The company is very low in cash.

For further details see:

Cue Biopharma: Too Long To Arrive At Topline Trial Data
Stock Information
Company Name: Cue Biopharma Inc.
Stock Symbol: CUE
Market: NASDAQ
Website: cuebiopharma.com
Menu
CUE CUE Quote CUE Short CUE News CUE Articles CUE Message Board
Get CUE Alerts

News, Short Squeeze, Breakout and More Instantly...